AnovaOS
Free for participating research sites.
Overview
AnovaOS by Anova Enterprises is an AI-enabled software-as-a-service (SaaS) platform designed to accelerate clinical trial enrollment and facilitate access to investigational treatments. It serves as an integrated research network connecting biopharmaceutical companies, research sites, and patients.
- What it does: AnovaOS leverages AI and proprietary algorithms to match patients to open clinical trials and investigational products for compassionate use. It integrates molecular, demographic, and clinical history data against trial eligibility criteria. The platform also supports site feasibility, study activation, patient enrollment, and data capture.
- Who it is for: The platform is intended for physicians, research staff, and clinical research sites across various care settings, including community practices and academic medical centers. It focuses on serious and life-threatening illnesses such as oncology, infectious diseases, neurology, immunology, cardiology, Alzheimer’s, diabetes, heart disease, Parkinson’s, and rare diseases.
- How it fits a clinical or practice workflow: AnovaOS integrates into existing clinical workflows, streamlining the process of screening subjects for studies. It aims to provide just-in-time access to investigational products and clinical trial opportunities at the point of care. Physicians and research staff can use it to efficiently match patients, secure access, and enroll them in trials or compassionate use programs.
- Notable capabilities: Key features include automated eligibility screening against trial protocols, secure and privacy-protected data handling, real-time updates on criteria changes and available studies, and a global network of over 200,000 active studies and 15,000 investigational products across 60,000+ research sites. It also supports the generation of real-world evidence and can be used for post-market surveillance.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-based patient matching
- Automated eligibility screening
- Global just-in-time research network
- Real-time updates on criteria changes and available studies
- Secure, privacy-protected data handling
- Integration into existing clinical workflows
- Registry-quality data collection
- Support for real-world evidence studies
- Direct access to key decision-makers at manufacturers
- Streamlined activation and enrollment
Use Cases
- Matching patients to clinical trials
- Matching patients to compassionate use programs
- Accelerating clinical trial enrollment
- Streamlining study feasibility for sponsors and sites
- Generating real-world evidence
- Managing clinical research portfolios and relationships
What Physicians Need to Know
Clinical Trial Matching
AnovaOS utilizes AI and proprietary algorithms to match patients to over 200,000 active clinical trials and compassionate use programs with high confidence. It cross-references molecular, demographic, and clinical history data against trial eligibility criteria in real-time.
Real-World Evidence Analysis
The AnovaOS global clinical registry is 21 CFR Part 11 compliant and provides a rich source of real-world evidence about research sites and patients. This data can inform clinical decision-making, support post-market surveillance programs, and aid in data-driven study design and marketing approvals.
Genomic Data Integration
AnovaOS leverages AI to match molecular data against eligibility criteria for active trials, indicating an ability to integrate genomic information for precision medicine approaches.
Collaboration Features
AnovaOS acts as an integrated research network connecting sponsors, sites, and physicians. It facilitates connections between 15,000 sponsors, 44,000+ research sites, and over 100,000 investigators, streamlining study feasibility, patient matching, and enrollment.
Publication Support
The platform supports the generation of quality evidence and scientific insight, which can contribute to publications.
Physician Tip
AnovaOS offers physicians a powerful tool to efficiently match patients to promising new treatments, including clinical trials and compassionate use programs, directly within their existing clinical workflows. The platform provides real-time updates on trial criteria and availability, ensuring access to the most current options. This can significantly reduce the time it takes to connect patients with investigational products, potentially improving patient outcomes, especially in complex and rare diseases.
AnovaOS is designed to integrate into current clinical workflows and supports the screening of subjects for studies. It also enables integration with preferred third-party electronic data capture (EDC) platforms. The platform's architecture is built to streamline access for those involved in research and accelerate the throughput of new therapies.
Details
| Category | Drug Discovery & Research, Oncology AI |
| Pricing | Free for participating research sites. — Free for participating research sites; Contact for sponsor/CRO pricing. |
| Deployment | Cloud-based (SaaS) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated AnovaOS is a software platform designed to accelerate clinical trials and patient matching, not a medical device requiring FDA clearance. It supports regulatory submissions by generating data and streamlining processes. |
| Integrations | |
| EHR | Not specified |
| Specialties | Hematology, Internal Medicine, Oncology |
What the Web Says
AnovaOS is a Software-as-a-Service (SaaS) platform designed to transform clinical trials by accelerating development, reducing costs, and increasing patient access to new treatments. It leverages AI and proprietary algorithms to match patients to clinical trials by analyzing molecular, demographic, and clinical history data against study eligibility criteria. The platform also supports real-world evidence studies and aims to streamline access for all involved in research.
Overall: MixedStrengths
- Accelerates clinical development and reduces costs
- Improves patient access to investigational treatments
- Utilizes AI for patient matching to clinical trials
- Integrates into current clinical workflows
- Provides real-time updates on criteria changes and available studies
- Offers a user-friendly platform with data security measures
Limitations
- Some Anova products (not specifically AnovaOS) have received criticism for declining quality, inconsistent temperatures, and noise in newer models
- Previous Anova products have faced issues with subscription models for app features
- Some users of other Anova software have found mobile interfaces difficult to use and search capabilities cumbersome
- A different Anova software product was noted to have a less modern dashboard and weaker technology platform compared to a competitor
- Customer service for other Anova products has received mixed reviews, with some positive and some negative experiences
Based on reviews from: Capterra, Software Advice, G2, Reddit, BioSpace, Anova Enterprises
Last updated: 2026-09-21
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate AnovaOS
Press & Coverage
Business Wire
Anova Expands Platform with Launch of Next-Generation eTMF Solution for Sponsors, CROs, and Research Sites
Anova launched its next-generation AnovaOS eTMF platform, a unified study document management solution that integrates eTMF, eISFs, automated document completion, workflow management, and eSignature to streamline clinical trial operations and improve compliance.
2026-07
Business Wire
Five Hundredth Urology Research Site Joins Anova's Global Urology Research Network
Anova announced the expansion of its virtual urology research network, delivered via its AnovaOS platform, reaching a milestone of 500 active clinical sites.
2026-04
Clinical Trials Arena
Anova introduces AI patient matching solution for clinical trials
Anova Enterprises launched the AnovaOS software-as-a-service (SaaS) platform, an AI-based patient matching solution for clinical trials, connecting sponsors to over 60,000 research-ready sites worldwide.
2025-12
Indian Pharma Post
Anova launches AI-powered patient matching platform to speed clinical trial enrollment
Anova Enterprises unveiled an AI-enabled patient matching solution, the AnovaOS SaaS platform, to accelerate clinical trial enrollment by cross-referencing patient data against over 200,000 ongoing trials.
2025-12
Anova Enterprises
Anova Launches Free AI-Enabled Clinical Trial Matching Solution as Part of a Global Just-in-Time Research Network
Anova launched a free AI-enabled patient matching solution as part of a global just-in-time research network and clinical trial infrastructure, aiming to speed trial enrollment and expand access to advanced research technology.
2025-12
Business Wire
Anova Today Announced the Enrollment of 550+ Patients at 50+ Sites in Six Months for a Single Study
Anova completed the enrollment of over 550 patients at more than 50 sites for a single study in just six months using its proprietary AnovaOSu2122 Platform, demonstrating accelerated patient enrollment and operational efficiency.
2025-12
BioSpace
Anova Launches Global Clinical Registry to Accelerate Research and Access to Promising New Treatments
Anova Enterprises launched a global clinical registry, the AnovaOSu00ae global clinical registry, to accelerate the development of new treatments by providing real-world evidence and streamlining administrative processes.
2025-09
Pharmabiz.com
Anova Enterprises introduces clinical registry to speed up research and access to promising new treatments
Anova Enterprises Inc. launched its 21 CFR Part 11 compliant AnovaOS global clinical registry to accelerate the development of promising new treatments by providing real-world evidence and supporting data-driven study design.
2025-09
Videos
Product demos, reviews, and walkthroughs for AnovaOS.
Urciuoli et al (research_paper 2013). Drivers and barriers affecting the usage of e-Customs.
CBRA
Frequently Asked Questions
AnovaOS is an AI-powered operating system designed to integrate and analyze healthcare data, aiming to provide insights for clinical decision support, operational efficiency, and personalized patient care. It's intended to assist physicians by streamlining workflows and offering data-driven perspectives, not to replace clinical judgment.
AnovaOS is built with robust security protocols and data encryption to ensure compliance with HIPAA and other healthcare data privacy regulations. It employs strict access controls, audit trails, and de-identification techniques to protect patient information.
While AnovaOS aims for accuracy, potential limitations include biases in the training data, which could lead to disparities in recommendations for certain patient populations. Physicians should also be aware that AI is a tool to augment, not replace, their clinical expertise and critical thinking.
AnovaOS differentiates itself through its comprehensive integration capabilities across various healthcare data sources and its focus on a holistic operating system approach rather than isolated AI tools. While other platforms may offer specific AI functionalities, AnovaOS aims for a more unified and interoperable ecosystem.
The pricing model for AnovaOS typically involves tiered subscriptions based on the scale of deployment and the specific modules or functionalities required. There are often different options tailored for individual practices, clinics, and larger hospital systems, with considerations for user count and data volume.
AnovaOS offers comprehensive technical support, including dedicated help desks and online resources, to assist physicians and their staff. Training programs, ranging from introductory courses to advanced usage workshops, are also provided to ensure effective adoption and utilization of the platform.
Yes, AnovaOS is designed for interoperability and can integrate with most existing Electronic Health Record (EHR) systems. The integration process typically involves API connections and data mapping, with support from the AnovaOS technical team to ensure a seamless and secure data flow.
Suggest an Edit →
| Last Verified: 2026-06-23 | First Added: 2026-06-23